OTSUKA HOLDINGS CO. LTD.

In News

Otsuka Holdings Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:OTSKY) 2026-04-28 - Seeking Alpha

Seeking Alpha - Apr 28, 2026

Otsuka Pharmaceutical to Acquire Transcend Therapeutics - PR Newswire

PR Newswire - Mar 27, 2026

Otsuka Can’t Reverse Generic’s Win Over Kidney Drug Patents (1) - Bloomberg Law News

Bloomberg Law News - May 21, 2026

Otsuka Holdings 1Q Net Y98.35B Vs Net Y85.00B - Moomoo

Moomoo - May 29, 2026

Daily Brief Japan: Mcdonald's Japan, CCReB Advisors, Duskin Co Ltd, Geechs Inc, Mixi Inc, Otsuka Holdings, AViC , Starts Publishing and more - Smartkarma

Smartkarma - Jun 09, 2026

Otsuka Holdings Co., Ltd.'s (TSE:4578) Intrinsic Value Is Potentially 93% Above Its Share Price - simplywall.st

simplywall.st - Oct 28, 2025

Otsuka Pharmaceutical Named Tokyo Sports Promotion Model Company (Sports Practice Category) Employee and Communities Health Initiatives Recognized｜March 4, 2026｜News Releases | Otsuka Pharmaceutical Co., Ltd. - otsuka.co.jp

otsuka.co.jp - Mar 04, 2026

US FDA approves Otsuka's drug for a type of kidney disease - Reuters

Reuters - Nov 25, 2025

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults - BioSpace

BioSpace - Jan 28, 2026

Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting - Yahoo Finance Singapore

Yahoo Finance Singapore - May 28, 2026

Otsuka Holdings Co: Otsuka Pharmaceutical to acquire Transcend Therapeutics, pay $700 million to shareholders upon acquisition - marketscreener.com

marketscreener.com - Mar 27, 2026

Is Otsuka Holdings Co., Ltd.'s (TSE:4578) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st

simplywall.st - Feb 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment